A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson's disease (Q48938567)

17 February 2018

title

A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson's disease (English)

1 reference

17 February 2018

1 reference

Hui-Qing Zhao

1

1 reference

17 February 2018

Fang-Fei Li

2

1 reference

17 February 2018

Zhan Wang

3

1 reference

17 February 2018

Xue-Mei Wang

4

1 reference

17 February 2018

Tao Feng

5

1 reference

17 February 2018

publication date

1 February 2016

1 reference

17 February 2018

published in

Neurological Sciences

1 reference

17 February 2018

volume

37

1 reference

17 February 2018

issue

5

1 reference

17 February 2018

page(s)

749-754

1 reference

17 February 2018

Parkinson disease survival: a population-based study

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Smoking and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Purification and characterization of a novel brain-specific 14-kDa protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Red blood cells are the major source of alpha-synuclein in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Neurodegenerative disease: amyloid pores from pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Biomarkers for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Alpha-synuclein protein is not scavenged in neuronal loss induced by kainic acid or focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2485-1

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

21 January 2018

1 reference

12 December 2020

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

1 reference

12 December 2020

Survival study of Parkinson disease in Olmsted County, Minnesota

1 reference

12 December 2020

Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study

1 reference

12 December 2020

Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease

1 reference

12 December 2020

Parkinsonism in Ontario: increased mortality compared with controls in a large cohort study

1 reference

12 December 2020

10.1007/S10072-016-2485-1

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018